NOVOCURE LTD's ticker is and the CUSIP is 67011XAB9. A total of 33 filers reported holding NOVOCURE LTD in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,074,016 | -68.6% | 4,750,000 | -68.3% | 0.18% | -58.4% |
| Q1 2023 | $12,980,000 | +16.9% | 15,000,000 | +20.0% | 0.44% | +27.1% |
| Q4 2022 | $11,103,750 | -24.5% | 12,500,000 | -24.2% | 0.35% | -23.4% |
| Q3 2022 | $14,708,000 | +9.2% | 16,500,000 | +6.5% | 0.46% | +6.8% |
| Q2 2022 | $13,466,000 | +47.6% | 15,500,000 | +55.0% | 0.43% | +112.9% |
| Q1 2022 | $9,125,000 | – | 10,000,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STEELHEAD PARTNERS LLC | 67,736,000 | $60,446,929 | 4.40% |
| BRAIDWELL LP | 131,834,000 | $117,582,745 | 3.94% |
| DeepCurrents Investment Group LLC | 38,391,000 | $34,368,176 | 1.34% |
| SHENKMAN CAPITAL MANAGEMENT INC | 16,861,000 | $14,946,863 | 0.93% |
| Context Capital Management, LLC | 12,489 | $11,139 | 0.82% |
| WOLVERINE ASSET MANAGEMENT LLC | 76,557,000 | $68,630,367 | 0.71% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 3,500,000 | $3,113,250 | 0.47% |
| Aequim Alternative Investments LP | 18,000,000 | $16,054,200 | 0.44% |
| Ionic Capital Management LLC | 2,000,000 | $1,781,555 | 0.42% |
| Verition Fund Management LLC | 27,771,000 | $24,768,955 | 0.39% |